WINSTROL 50 Inject Para Pharma

£57.00

Stanozolol injection provides researchers with a synthetic anabolic compound for investigating DHT-derived steroid mechanisms. Para Pharma formulation offers 50mg/ml concentration for controlled laboratory studies examining anabolic pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

WINSTROL 50 Inject Para Pharma
WINSTROL 50 Inject Para Pharma
£57.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding WINSTROL 50 Inject Para Pharma

Stanozolol injection is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone, offering researchers a valuable tool for investigating anabolic mechanisms in controlled laboratory settings. This injectable formulation from Para Pharma provides precise dosing capabilities for researchers examining steroid receptor interactions and tissue-selective anabolic effects. Scientists studying muscle biology, bone metabolism, and androgen receptor pathways frequently utilise stanozolol in their research protocols. The compound’s unique structural modifications distinguish it from testosterone-based steroids, making it particularly useful for comparative studies. Researchers at Stroid UK Shop have employed stanozolol in various preclinical investigations examining anabolic processes.

Molecular Research Framework

Stanozolol demonstrates selective tissue distribution patterns that make it valuable for researchers investigating compartmentalised anabolic effects. The compound exhibits reduced 5α-reductase activity compared to testosterone derivatives, providing researchers with insights into alternative androgenic pathways. Studies examining stanozolol’s interaction with androgen receptors reveal distinct binding characteristics that contribute to its tissue-selective properties. Research teams investigating injectable anabolic compounds often incorporate stanozolol protocols when examining differential receptor activation patterns. The injectable delivery system enables researchers to achieve consistent plasma concentrations, facilitating reproducible experimental outcomes across multiple research phases.

Laboratory Specifications

Stanozolol Injection Research Specifications
Parameter Specification
Concentration 50mg/ml
Chemical Name 17-methyl-2’H -5α-androst-2-eno[3,2-c]-pyrazol-17β-ol
Molecular Formula C₂₁H₃₂N₂O
Molecular Weight 328.49 g/mol
CAS Registry 10418-03-8
Storage Temperature Room temperature, protected from light
Solubility Oil-based injection solution
Research Applications Androgen receptor studies, anabolic pathway research

Research teams studying metabolic processes often combine stanozolol investigations with complementary compounds from selective androgen receptor modulator categories. Additionally, researchers examining growth factor pathways frequently incorporate peptide research compounds alongside stanozolol protocols to examine synergistic cellular mechanisms.

Research Compliance Statement

This stanozolol injection is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical application, or therapeutic use. Research institutions must ensure proper handling protocols, appropriate storage conditions, and compliance with institutional research guidelines when utilising this compound in approved scientific investigations.

Related